HOOKIPA Pharma (HOOK) Competitors $0.92 +0.01 (+1.09%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$0.92 -0.01 (-0.54%) As of 07/25/2025 07:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HOOK vs. ANL, RENB, KRON, VTVT, ATNM, PDSB, ANVS, DTIL, SNTI, and NRXPShould you be buying HOOKIPA Pharma stock or one of its competitors? The main competitors of HOOKIPA Pharma include Adlai Nortye (ANL), Renovaro (RENB), Kronos Bio (KRON), vTv Therapeutics (VTVT), Actinium Pharmaceuticals (ATNM), PDS Biotechnology (PDSB), Annovis Bio (ANVS), Precision BioSciences (DTIL), Senti Biosciences (SNTI), and NRx Pharmaceuticals (NRXP). These companies are all part of the "pharmaceutical products" industry. HOOKIPA Pharma vs. Its Competitors Adlai Nortye Renovaro Kronos Bio vTv Therapeutics Actinium Pharmaceuticals PDS Biotechnology Annovis Bio Precision BioSciences Senti Biosciences NRx Pharmaceuticals Adlai Nortye (NASDAQ:ANL) and HOOKIPA Pharma (NASDAQ:HOOK) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, dividends, risk and institutional ownership. Which has higher valuation and earnings, ANL or HOOK? HOOKIPA Pharma has higher revenue and earnings than Adlai Nortye. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdlai NortyeN/AN/A-$51.87MN/AN/AHOOKIPA Pharma$43.95M0.26-$43.50M-$5.85-0.16 Do insiders and institutionals have more ownership in ANL or HOOK? 35.2% of Adlai Nortye shares are held by institutional investors. Comparatively, 63.9% of HOOKIPA Pharma shares are held by institutional investors. 3.3% of HOOKIPA Pharma shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is ANL or HOOK more profitable? Adlai Nortye has a net margin of 0.00% compared to HOOKIPA Pharma's net margin of -785.66%. Adlai Nortye's return on equity of 0.00% beat HOOKIPA Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Adlai NortyeN/A N/A N/A HOOKIPA Pharma -785.66%-120.09%-77.14% Which has more risk & volatility, ANL or HOOK? Adlai Nortye has a beta of -0.95, indicating that its share price is 195% less volatile than the S&P 500. Comparatively, HOOKIPA Pharma has a beta of 0.89, indicating that its share price is 11% less volatile than the S&P 500. Does the media favor ANL or HOOK? In the previous week, HOOKIPA Pharma had 4 more articles in the media than Adlai Nortye. MarketBeat recorded 5 mentions for HOOKIPA Pharma and 1 mentions for Adlai Nortye. Adlai Nortye's average media sentiment score of 0.94 beat HOOKIPA Pharma's score of 0.40 indicating that Adlai Nortye is being referred to more favorably in the media. Company Overall Sentiment Adlai Nortye Positive HOOKIPA Pharma Neutral Do analysts rate ANL or HOOK? Adlai Nortye presently has a consensus price target of $9.00, indicating a potential upside of 525.00%. HOOKIPA Pharma has a consensus price target of $4.50, indicating a potential upside of 389.13%. Given Adlai Nortye's higher possible upside, equities research analysts clearly believe Adlai Nortye is more favorable than HOOKIPA Pharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adlai Nortye 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00HOOKIPA Pharma 0 Sell rating(s) 2 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.33 SummaryHOOKIPA Pharma beats Adlai Nortye on 8 of the 13 factors compared between the two stocks. Get HOOKIPA Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for HOOK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HOOK and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HOOK vs. The Competition Export to ExcelMetricHOOKIPA PharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$11.09M$3.07B$5.70B$9.50BDividend YieldN/A2.37%4.58%4.01%P/E Ratio-0.1621.1828.1020.05Price / Sales0.26286.17429.0189.19Price / CashN/A42.7636.2258.56Price / Book0.228.378.665.87Net Income-$43.50M-$55.19M$3.25B$258.55M7 Day Performance-19.30%5.88%4.22%3.73%1 Month Performance-26.40%17.33%10.51%11.75%1 Year Performance-85.04%4.42%34.40%18.03% HOOKIPA Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HOOKHOOKIPA Pharma3.0691 of 5 stars$0.92+1.1%$4.50+389.1%-85.4%$11.09M$43.95M-0.16160News CoverageHigh Trading VolumeANLAdlai Nortye1.8974 of 5 stars$1.52+1.3%$9.00+492.1%-57.6%$55.35M$5M0.00127RENBRenovaro2.2249 of 5 stars$0.31-2.8%N/A-75.3%$54.54MN/A-0.4020KRONKronos BioN/A$0.88+1.5%$1.63+84.7%-34.3%$53.72M$9.85M-0.82100VTVTvTv Therapeutics1.54 of 5 stars$16.55+2.4%$35.50+114.5%-26.6%$53.57M$1.02M-5.509News CoveragePositive NewsATNMActinium Pharmaceuticals2.4612 of 5 stars$1.69-1.2%$4.00+136.7%N/A$52.72MN/A-1.2230Positive NewsPDSBPDS Biotechnology1.2528 of 5 stars$1.15flat$9.00+682.6%-70.1%$52.57MN/A-1.2220ANVSAnnovis Bio1.8523 of 5 stars$2.53-4.5%$18.00+611.5%-72.1%$51.64MN/A-1.173DTILPrecision BioSciences4.1033 of 5 stars$4.65+0.9%$47.00+910.8%-49.4%$51.12M$68.70M-2.31200Upcoming EarningsSNTISenti Biosciences2.2678 of 5 stars$1.98+1.5%$8.50+329.3%-16.8%$50.86M$2.56M-0.184Gap UpNRXPNRx Pharmaceuticals2.5264 of 5 stars$2.98+1.4%$28.50+856.4%+28.2%$50.83MN/A-1.482 Related Companies and Tools Related Companies Adlai Nortye Competitors Renovaro Competitors Kronos Bio Competitors vTv Therapeutics Competitors Actinium Pharmaceuticals Competitors PDS Biotechnology Competitors Annovis Bio Competitors Precision BioSciences Competitors Senti Biosciences Competitors NRx Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HOOK) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding HOOKIPA Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share HOOKIPA Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HOOK Stock Alerts